A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShengjing Hospital
About this trial
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.
Eligibility criteria
Qualifiers
age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography
Disqualifiers
pregnancy
reception of reperfusion treatment before admission
missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 1 trial groupLocations
1Shenjing Hospital of CHINA MEDICAL UNIVERSITY ShenyangLiaoning, China
Sponsors and collaborators
Shengjing Hospital
Lead sponsor
Source ClinicalTrials.gov